about
The mTOR signalling pathway in human cancerCore I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroidENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcomePoorly Differentiated and Undifferentiated Thyroid CarcinomasTelomerase Activation in Hematological MalignanciesThe Role of ATRX in the Alternative Lengthening of Telomeres (ALT) PhenotypeSTAT3 negatively regulates thyroid tumorigenesisProliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer.SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanomaPolymorphisms in the TNFA and IL6 genes represent risk factors for autoimmune thyroid diseaseMulticentre validation study of nucleic acids extraction from FFPE tissues.Primary squamous cell carcinoma of the thyroid diagnosed as anaplastic carcinoma: failure in fine-needle aspiration cytology?TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomasInvolvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone.Vascular invasion in thyroid and gastric carcinomas.Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migrationDifferentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature.Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomasIL6-174 G>C Polymorphism (rs1800795) Association with Late Effects of Low Dose Radiation Exposure in the Portuguese Tinea Capitis Cohort.Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells.TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromesIntragenic mutations in thyroid cancer.Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior.Thyroid hormone as a regulator of tumor induced angiogenesis.GRIM-19 function in cancer development.How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid CancerParaganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review.The biology and the genetics of Hurthle cell tumors of the thyroid.Insights into melanoma: targeting the mTOR pathway for therapeutics.RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?Prognostic biomarkers in thyroid cancer.Telomerase promoter mutations in cancer: an emerging molecular biomarker?Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation.
P50
Q24627306-C00F7F75-5C12-40A6-A30A-AAE4AFB7C0C7Q24796416-91A090BD-85DF-4347-8CEA-4DC1A33EF602Q26778154-C9A161AE-8BCF-40FE-8CA3-AA9614CAD580Q26801388-4DD94EE4-0853-4D65-8F2E-5BE2E7052DADQ28068238-06B924BE-A421-4027-93CA-4B1DC92F1756Q28071562-466D243A-6B65-444A-A752-9D76B27853E3Q28505424-D4E58B75-589E-4423-90D6-A6AB6AFAB475Q33514138-084BB59A-512A-4437-AFD6-9C36D1A2080DQ33822934-B588647E-BCD1-4C7C-AE34-2575CD8A0EA0Q33853615-86C0A597-8643-4B5A-BB29-0095132F5337Q34051020-B8E53066-9844-443B-B5FD-2BA8E523180BQ34105829-1526CB7D-9BD8-4C7F-9372-D7F12B2563E8Q34247151-A092A619-8C9C-4C98-A63D-1E356B353E06Q34313648-8A401E7E-4DA4-489C-8A10-668C5CC9E64AQ34636091-4B4C09BF-D609-4EFC-A8C4-2BB739C4DE06Q35055394-409387CB-9789-4458-9495-DFE015138209Q35231712-31F2F1E9-0538-4AC3-BB38-E2F8A64F3217Q35600108-56EE78C9-54FE-4FA2-9DB3-BFE3530B1A9EQ35731037-AF400333-3831-4263-B26A-1CF883BC49D8Q36142967-EAF91F39-F209-4241-B2F9-530D61D4B3FCQ36615843-209AAD0A-919C-4B9F-9116-F6EA9E5F5799Q36695151-7D7DABD6-90E9-46F1-B03E-5543B5C13A83Q36809668-9DBBE8F1-9E48-450F-98D0-6F8393A296DAQ37058301-89D15806-01BF-4604-88E0-41955001B0CEQ37093384-5653AAA8-CC2C-427B-B479-8CEC46A7B79BQ37172760-905F4E75-D313-4DA5-8FA7-A51EE6327453Q37588399-5C0ED0A7-1AAB-47E2-8436-2B627FA2528AQ37823747-645D2DFD-5DFC-4E0E-AE0D-E7F78FDB8735Q37888005-BB170A60-FD39-4C20-8B91-35CEA561CD79Q37902072-3CCFE4CC-447A-4421-AE2A-839B363A4C8EQ37985598-A949E0B5-9FA8-41C4-8F69-63CBB0A53E1BQ38003587-F6EBC6D3-C116-49BF-9426-C1962B7AEFC3Q38012466-5C653B35-98C4-4397-B894-970EA6B47EABQ38026893-B74595AE-F573-4AA4-9C0E-2BFCEBE9CB90Q38176686-D158B305-D4A7-42AF-91D8-655C146CA782Q38184374-CEF604D6-9FE4-41DE-A3D1-AA08D780D717Q38232447-CE07F3CE-5114-4E87-B9BF-8A226FD3D6CCQ38754009-0AB35869-16D2-4C3A-8CA7-7AC61359A00AQ38799394-365C7A9F-4D1F-4872-A516-33901106E141Q38844306-60827A90-23CD-4F9D-947A-81DD0BD1F082
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Paula Soares
@ast
Paula Soares
@en
Paula Soares
@es
Paula Soares
@nl
Paula Soares
@sl
type
label
Paula Soares
@ast
Paula Soares
@en
Paula Soares
@es
Paula Soares
@nl
Paula Soares
@sl
altLabel
Soares P
@en
prefLabel
Paula Soares
@ast
Paula Soares
@en
Paula Soares
@es
Paula Soares
@nl
Paula Soares
@sl
P1053
B-6054-2008
P106
P108
P1153
35478020200
57195213812
P21
P2798
P31
P3829
P3835
paula-soares7
P496
0000-0001-9607-6998